Status:
UNKNOWN
Evaluation of Reactive Oxygen Metabolites in the Value of COPD
Lead Sponsor:
Beijing Chao Yang Hospital
Conditions:
COPD(Chronic Obstructive Pulmonary Disease)
Eligibility:
All Genders
40-75 years
Brief Summary
This study through the long-term observation followed up for 2 years to find the change of the COPD patients blood ROMs, systematically evaluate the relationship between ROMs and the severity of COPD....
Detailed Description
Reactive oxygen metabolites (reactive oxygen metabolites, ROMs) test is a method by measuring the total reactive oxygen metabolites (ROMs) content in blood so as to evaluate the overall level of oxida...
Eligibility Criteria
Inclusion
- Clinical diagnosis of COPD according to GOLD 2013
Exclusion
- A history of asthma or other chronic lung diseases Take Antioxidant therapy There are new or recurrent symptomatic myocardial ischemia, severe arrhythmia, cardiac insufficiency cerebrovascular disease Senile dementia or cognitive impairment cancer Severe liver and kidney and other viscera function insufficiency Language communication barriers Limb activity disorder The last 3 months participated in sports training
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2017
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT02297633
Start Date
October 1 2014
End Date
July 1 2017
Last Update
November 21 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Respiratory Institute;Beijing chaoyang hospital
Beijing, Beijing Municipality, China, 100020